Sara Bringhen Selected Research

Salvage Therapy

3/2022	Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients.
1/2021	Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
2/2019	Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study).
1/2018	Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN).
3/2017	Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma.
8/2007	Time to first disease progression, but not beta2-microglobulin, predicts outcome in myeloma patients who receive thalidomide as salvage therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sara Bringhen Research Topics

Disease

88	Multiple Myeloma 10/2022 - 08/2002
8	Neoplasms (Cancer) 11/2020 - 07/2010
6	Neutropenia 01/2021 - 07/2011
5	Infections 01/2021 - 06/2013
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2017 - 12/2010
3	Renal Insufficiency (Renal Failure) 10/2018 - 10/2008
3	Anemia 01/2018 - 10/2008
2	Thrombocytopenia (Thrombopenia) 05/2020 - 07/2011
2	Disease Progression 10/2017 - 08/2007
2	Thromboembolism 03/2011 - 03/2006
2	Thrombosis (Thrombus) 10/2007 - 03/2006
1	Hypertension (High Blood Pressure) 01/2021
1	Residual Neoplasm 12/2020
1	Frailty 01/2020
1	Immunoglobulin Light-chain Amyloidosis 01/2018
1	Obesity 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Leukemia 10/2017
1	Cardiotoxicity 01/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2017
1	Bone Diseases (Bone Disease) 10/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 09/2015
1	Pulmonary Embolism 01/2012
1	Venous Thromboembolism 01/2012
1	Sudden Death 03/2011
1	Fever (Fevers) 10/2008
1	Hypocalcemia 10/2008
1	Bone Marrow Diseases (Bone Marrow Disease) 08/2007
1	Ovarian Neoplasms (Ovarian Cancer) 07/2007
1	Pathologic Complete Response 03/2007

Drug/Important Bio-Agent (IBA)

26	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 01/2004
26	Thalidomide (Thalomid)FDA Link 01/2018 - 01/2004
25	Melphalan (Alkeran)FDA LinkGeneric 12/2020 - 08/2002
24	Bortezomib (Velcade)FDA Link 01/2021 - 04/2007
23	Lenalidomide (CC 5013)FDA Link 10/2022 - 07/2007
23	Prednisone (Sone)FDA LinkGeneric 12/2020 - 03/2006
12	carfilzomibIBA 03/2022 - 10/2013
10	Proteasome InhibitorsIBA 09/2020 - 07/2007
8	pomalidomideIBA 01/2022 - 10/2013
8	Monoclonal AntibodiesIBA 01/2022 - 08/2014
7	isatuximabIBA 01/2022 - 01/2019
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 10/2013
7	Immunomodulating AgentsIBA 12/2020 - 10/2013
6	Pharmaceutical PreparationsIBA 09/2020 - 09/2012
4	Alkylating AgentsIBA 09/2020 - 07/2007
3	elotuzumabIBA 10/2022 - 01/2021
3	daratumumabIBA 01/2022 - 01/2019
3	melflufenIBA 01/2021 - 05/2020
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2015 - 03/2011
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2012 - 03/2006
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2012 - 10/2007
2	ixazomibIBA 12/2021 - 12/2020
2	AntigensIBA 11/2020 - 01/2019
2	Zoledronic Acid (Zometa)FDA Link 10/2015 - 10/2008
2	Hemoglobins (Hemoglobin)IBA 10/2015 - 08/2007
2	defibrotideIBA 03/2012 - 07/2010
2	liposomal doxorubicin (Doxil)FDA Link 08/2010 - 04/2007
1	Bispecific AntibodiesIBA 11/2020
1	Immunoconjugates (Immunoconjugate)IBA 11/2020
1	Peptide Hydrolases (Proteases)FDA Link 09/2020
1	AminopeptidasesIBA 09/2020
1	Peptides (Polypeptides)IBA 09/2020
1	GoldIBA 09/2020
1	thiamine triphosphorate (TTP)IBA 01/2020
1	SteroidsIBA 01/2020
1	felzartamabIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	CytokinesIBA 01/2019
1	PanobinostatIBA 01/2018
1	AnthracyclinesIBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017
1	Histone Deacetylase InhibitorsIBA 01/2017
1	Pamidronate (Aredia)FDA LinkGeneric 10/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2015
1	Proteins (Proteins, Gene)FDA Link 10/2014
1	cyclopentenyl cytosineIBA 07/2014
1	Warfarin (Coumadin)FDA LinkGeneric 03/2011
1	Drug CombinationsIBA 12/2010
1	C-Reactive ProteinIBA 08/2007
1	Indicators and Reagents (Reagents)IBA 08/2007
1	CreatinineIBA 08/2007
1	Immunoglobulin A (IgA)IBA 08/2007

Therapy/Procedure

29	Therapeutics 04/2021 - 08/2002
9	Stem Cell Transplantation 12/2020 - 08/2007
6	Salvage Therapy 03/2022 - 08/2007
3	Drug Therapy (Chemotherapy) 10/2018 - 08/2002
1	Immunotherapy 11/2020
1	Cardiopulmonary Resuscitation (CPR) 03/2016
1	Drug Tapering 06/2014
1	Transplantation 03/2014
1	Duration of Therapy 03/2014
1	VMP regimen 07/2011
1	Autologous Transplantation 02/2010
1	Homologous Transplantation 03/2007
1	Investigational Therapies (Experimental Therapy) 12/2006